Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "Appointed"

271 News Found

Azelis signs distribution agreement with Evonik to expands pharmaceutical offering in Malaysia and Singapore
Supply Chain | March 13, 2025

Azelis signs distribution agreement with Evonik to expands pharmaceutical offering in Malaysia and Singapore

This expanded partnership helps Evonik to streamline its distribution model in Asia Pacific


Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business
People | March 07, 2025

Eris Lifesciences appoints Murari Ranganathan to drive cardiometabolic business

Prior to joining Eris, Ranganathan was Commercial Director, Women's Health, Metabolics, and International Business at Abbott India Limited


Natco Pharma appoints Bhimrao Dattu Jadhav as Senior VP – Operations (Formulations) for Pharma Division – Kothur
People | March 04, 2025

Natco Pharma appoints Bhimrao Dattu Jadhav as Senior VP – Operations (Formulations) for Pharma Division – Kothur

Jadhav has completed his B.Pharmacy and is having 30+ years of rich experience in operation management in pharmaceutical Industry


GlaxoSmithkline Pharmaceuticals appoints Carson Dalton as Executive VP - Communications and Government Affairs
People | March 04, 2025

GlaxoSmithkline Pharmaceuticals appoints Carson Dalton as Executive VP - Communications and Government Affairs

Carson brings with him over two decades of experience in Communications, Public Affairs, and Sustainability


Sanofi updates on extraintestinal pathogenic E. coli vaccine phase 3 clinical study
News | February 17, 2025

Sanofi updates on extraintestinal pathogenic E. coli vaccine phase 3 clinical study

No safety signals related to the vaccine candidate were identified


AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
People | February 15, 2025

AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors

Richard A. Gonzalez to retire from the board of directors effective July 1, 2025


Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial
News | February 15, 2025

Bristol Myers Squibb Provides Update on Phase 3 RELATIVITY-098 Trial

The safety profile of Opdualag observed in this analysis was consistent with the known profiles of nivolumab and relatlimab


Peter Bains to replace Jonathan Hunt as CEO of Syngene
People | February 11, 2025

Peter Bains to replace Jonathan Hunt as CEO of Syngene

Peter Bains has over three decades of experience in the biotech and pharmaceutical industry


Pharmexcil appoints Bhavin Mukund Mehta as Vice Chairman
People | February 05, 2025

Pharmexcil appoints Bhavin Mukund Mehta as Vice Chairman

Mehta is an industry veteran with over 25 years of experience in the pharmaceutical industry